Chemed (CHE) vs Pennant Group (PNTG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pennant Group (PNTG) has outperformed Chemed (CHE) over the past year, gaining 59.6% versus a gain of 15.0%. Over five years, PNTG leads with a +52.7% price change compared with +16.6% for CHE. Chemed is the larger company by market cap ($6.51 billion vs $1.41 billion), about 4.6 times the size.
On valuation, Chemed trades at a lower forward P/E (18.1x vs 25.4x for Pennant Group). Chemed pays a dividend yielding 0.48%, while Pennant Group does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | PNTG |
|---|---|---|
| Share price | $498.25 | $40.37 |
| Market cap | $6.51B | $1.41B |
| 1-day change | -0.64% | +1.89% |
| YTD return | +17.20% | +43.41% |
| 1-year return | +14.99% | +59.63% |
| 5-year return | +16.58% | +52.74% |
| P/E ratio (TTM) | 25.06 | 44.36 |
| Forward P/E | 18.11 | 25.44 |
| EPS (TTM) | $19.88 | $0.91 |
| Dividend yield | 0.48% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $2.53B | — |
| Revenue growth (YoY) | +4.06% | — |
| Net income (latest FY) | $265.24M | — |
| Gross margin | 32.54% | — |
| Operating margin | 13.37% | — |
| Net margin | 10.48% | — |
| 52-week high | $557.00 | $42.74 |
| 52-week low | $365.21 | $22.26 |
| Distance from 52-week high | -10.55% | -5.55% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +14.72% | +16.00% |
| Average volume | 159.79K | 314.73K |
| Shares outstanding | 13.07M | 34.93M |
| Employees | 15,811 | 9,700 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Chemed is about 4.6 times larger than Pennant Group by market value ($6.51B vs $1.41B).
- PNTG has outperformed CHE by 44.6 percentage points over the past year.
- Pennant Group trades at a higher earnings multiple (44.4x vs 25.1x trailing P/E).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About Pennant Group
PNTG stock →The Pennant Group, Inc. provides healthcare services in the United States.
Health Care · Medical/Nursing Services · 9,700 employees
CHE vs PNTG FAQ
Which is bigger, Chemed or Pennant Group?
Chemed (CHE) is larger, with a market capitalization of $6.51B compared with $1.41B for Pennant Group (PNTG).
Which stock has performed better over the past year, CHE or PNTG?
PNTG returned +59.63% over the past 12 months, compared with +14.99% for CHE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CHE or PNTG?
CHE has the lower trailing P/E at 25.1, versus 44.4 for PNTG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Chemed or Pennant Group?
Chemed pays a dividend yielding 0.48%, while Pennant Group does not currently pay a regular dividend.
Are Chemed and Pennant Group in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.